Carla F. Penteado-Franco
Campinas, RS, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Reduced blood pressure in sickle cell disease is associated with decreased angiotensin converting enzyme (ACE) activity and is not modulated by ACE inhibition.
Journal: PloS one
Published: September 16, 2021
Beneficial Effects of Soluble Guanylyl Cyclase Stimulation and Activation in Sickle Cell Disease Are Amplified by Hydroxyurea: In Vitro and In Vivo Studies.
Journal: The Journal of pharmacology and experimental therapeutics
Published: December 13, 2019
Progression of micturition dysfunction associated with the development of heart failure in rats: Model of overactive bladder.
Journal: Life sciences
Published: February 26, 2019
Amiloride Relaxes Rat Corpus Cavernosum Relaxation In Vitro and Increases Intracavernous Pressure In Vivo.
Journal: The journal of sexual medicine
Published: August 31, 2018
A thalidomide-hydroxyurea hybrid increases HbF production in sickle cell mice and reduces the release of proinflammatory cytokines in cultured monocytes.
Journal: Experimental hematology
Published: August 18, 2017
Urinary Bladder Dysfunction in Transgenic Sickle Cell Disease Mice.
Journal: PloS one
Published: May 12, 2015
Association of Nitric Oxide Synthase and Matrix Metalloprotease Single Nucleotide Polymorphisms with Preeclampsia and Its Complications.
Journal: PloS one
Published: April 25, 2015
Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea.
Journal: Haematologica
Published: October 27, 2014
Last Updated: 09/26/2026